O-Shot® Injection Treatment In Dubai

The treatment includes a routine blood draw followed by several small injections into sensitive intimate tissue, so some pressure, pinching or brief stinging is possible. A topical or local anaesthetic is used beforehand to improve comfort, and many patients tolerate the procedure without sedation. Sensitivity varies, especially when vaginal dryness, inflammation or pelvic pain is already present. Mild tenderness, swelling or light spotting may occur for a short time afterwards. Tell your doctor immediately if you feel significant or sharp pain during the procedure. Pain that is severe, worsening or accompanied by fever, heavy bleeding, unusual discharge or difficulty urinating after treatment should be assessed promptly.

The O-Shot uses platelet-rich plasma prepared from your own blood, which reduces the likelihood of an immune or allergic reaction to the PRP itself. However, autologous PRP does not make the procedure risk-free. Possible effects include pain, bruising, swelling, light bleeding or spotting, infection, irritation and a temporary change or worsening of symptoms; injury to nearby tissue, nerves or blood vessels is uncommon but possible. Reactions can also occur to local anaesthetic, antiseptic or dressings. Safety depends on an appropriate medical assessment, sterile preparation, careful injection technique and a trained clinician. Your doctor should review infections, medications, bleeding risks, allergies and relevant medical conditions before treatment.

A suitable candidate is an adult seeking a non-surgical option for concerns such as reduced genital sensation, arousal or orgasm difficulty, vaginal dryness, or mild stress urinary leakage, after a medical assessment has identified realistic treatment goals. These symptoms can have many causes, including menopause-related tissue changes, medication effects, pelvic-floor dysfunction, infection, vulval or vaginal conditions, pain disorders, neurological or metabolic illness, and psychological or relationship factors. An O-Shot should therefore not be offered as a one-size-fits-all solution. A consultation in Dubai should include your history, examination when indicated, review of current treatments and discussion of established alternatives. Benefit cannot be guaranteed because the clinical evidence remains limited and PRP protocols are not standardised.

There is no scientifically established duration that applies to every patient. If improvement occurs, some women notice changes over the first few weeks, with further change developing over the following two to three months. The degree and duration of benefit vary with the underlying problem, hormonal status, tissue health, PRP preparation and individual response. Published studies use different injection protocols and generally have limited follow-up, so a guaranteed 12–18-month result is not supported by strong evidence. Some patients may report longer-lasting improvement, while others notice little or no meaningful change. Repeat or “maintenance” treatment should not be automatic; it should follow reassessment of symptoms, benefits, adverse effects and other appropriate treatment options.

It may form part of an individualised plan, but combinations should be based on the diagnosis rather than used automatically. Depending on the concern, care may include pelvic-floor physiotherapy, lubricants or vaginal moisturisers, treatment for infection or pain, medication review, counselling or sex therapy, and evidence-based treatment for genitourinary symptoms of menopause, such as local vaginal oestrogen when medically appropriate. Energy-based vaginal laser or radiofrequency treatments have separate indications, limitations and risks, and combining them with PRP has not been proven to guarantee better results. Your doctor should explain the evidence, recovery time, cost and treatment sequence for every component so that effectiveness and side effects can be assessed clearly.

Some small studies and patient series report improvements in aspects of female sexual function after vaginal or clitoral PRP injections, and a recent controlled trial found improvement in overall patient-reported sexual function. However, results are not consistent across individual domains such as desire, arousal, lubrication, orgasm, satisfaction and pain. Studies also differ in PRP preparation, injection sites, number of sessions and the types of patients treated. This means the O-Shot is best described as an emerging treatment, not a guaranteed way to produce stronger orgasms or increased sensitivity. A proper assessment is important because sexual difficulties are often multifactorial, and treatment may also need to address hormonal changes, pain, medication effects, pelvic-floor function and emotional or relationship factors.

PRP injections are being studied for stress urinary incontinence—the leakage that may occur with coughing, sneezing, laughing or exercise—but they are not an established first-line treatment. Some small studies and reviews suggest possible short-term improvement, while a randomised placebo-controlled trial of a single anterior vaginal-wall PRP injection did not find a significant benefit over saline. Current research is limited by small participant numbers, different PRP and injection protocols, and short follow-up. Women with urinary leakage should first have the type and severity confirmed, because urgency incontinence, infection and other bladder conditions require different care. Pelvic-floor muscle training and other established conservative, medical or surgical options should be discussed alongside the uncertain benefits of PRP.

Follow the personalised instructions given by your treating doctor. Patients are commonly advised to avoid vaginal intercourse, tampons and inserting products for about 48–72 hours, and to postpone strenuous exercise, swimming, hot baths and saunas for around 48 hours. Wait longer if tenderness, swelling or spotting has not settled. Gentle daily activity is usually possible, but recovery varies with the injection sites and individual response. Do not apply unprescribed creams or medicines to the area. Contact the clinic promptly if you develop fever, increasing pain or swelling, heavy or persistent bleeding, offensive discharge, difficulty passing urine or another unexpected symptom. Your clinician may adjust these restrictions if PRP is combined with another procedure.

Treatment is generally postponed or avoided when there is an active urinary, vaginal or sexually transmitted infection; unexplained vaginal bleeding; an unassessed vulval or vaginal lesion; pregnancy; or incomplete recovery after childbirth or intimate surgery. Extra caution is needed with platelet or clotting disorders, significant anaemia, uncontrolled medical illness, immune suppression, active cancer in the treatment area, or medicines that affect bleeding or platelet function. Suitability also depends on the anaesthetic and PRP system being used. Never stop anticoagulants, antiplatelet medicines or anti-inflammatory medication without guidance from the clinician who prescribed them. A medical history, examination when appropriate and medication review are required before deciding whether the procedure can be performed safely.

The price of an O-Shot in Dubai can vary according to the medical consultation and examination required, the PRP preparation system, the treatment areas and injection protocol, local anaesthesia, and whether follow-up or another therapy is included. Because symptoms such as dryness, painful sex, orgasm difficulty and urinary leakage can have different causes, an accurate quotation should follow an assessment rather than be based on a generic package. Ask whether the quoted price includes the initial consultation, any necessary tests, the PRP procedure, aftercare and review. When comparing clinics, consider the treating clinician’s qualifications, sterile technique, product traceability, informed-consent process and management of complications—not price alone. The clinic can provide a personalised cost after confirming suitability and treatment goals.